Farida Sohrabji, Ph.D., professor and associate chair, Department of Neuroscience and Experimental Therapeutics, was recently elected Fellow of the American Heart Association’s Stroke Council.
Election as a Fellow of the American Heart Association (FAHA) recognizes health care professionals’ scientific and professional accomplishments, volunteer leadership and service. Fellowship is open to physicians, scientists, nurses and other healthcare professionals with a major and productive interest in cardiovascular diseases and stroke. The American Heart Association is one of the world’s most eminent organizations of cardiovascular and stroke professionals.
Sohrabji’s research program focuses on brain-immune interactions regulated by estrogen and its implications for neuro-inflammatory diseases such as stroke in women. Additionally, she is also interested in estrogen’s interactions with other endogenous and environmental endocrine mediators, including Vitamin D hormone and the peptide hormone Insulin-like Growth Factor (IGF)-1. Her current studies use an animal model to examine age and sex differences in recovery from stroke, focusing at the cellular level on the endothelium and astrocytes, which are the principal components of the blood brain barrier. At the molecular level, she and her team are examining sex and age differences in miRNA and epigenetic markers, with a view to developing biomarkers for diseases and uncovering new therapeutic targets.
Sohrabji also serves as the Director of the Women’s Health in Neuroscience Program at the College of Medicine, is on the steering committee of the Texas Alzheimer’s Research and Care Consortium (TARCC), and is a faculty member with the Texas A&M Institute for Neuroscience (TAMIN).